| Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats M Mejias, E Garcia‐Pras, C Tiani, R Miquel, J Bosch, M Fernandez Hepatology 49 (4), 1245-1256, 2009 | 392 | 2009 |
| Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats M Fernandez, M Mejias, B Angermayr, JC Garcia-Pagan, J Rodés, ... Journal of hepatology 43 (1), 98-103, 2005 | 310 | 2005 |
| Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet‐derived growth factor blockade in rats M Fernandez, M Mejias, E Garcia‐Pras, R Mendez, JC Garcia‐Pagan, ... Hepatology 46 (4), 1208-1217, 2007 | 248 | 2007 |
| Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension M Mejias, E Garcia-Pras, J Gallego, R Mendez, J Bosch, M Fernandez Journal of hepatology 52 (4), 529-539, 2010 | 149 | 2010 |
| Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension C Tiani, E Garcia-Pras, M Mejias, A De Gottardi, A Berzigotti, J Bosch, ... Journal of hepatology 50 (2), 296-305, 2009 | 108 | 2009 |
| Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats B Angermayr, M Mejias, J Gracia-Sancho, JC Garcia-Pagan, J Bosch, ... Journal of hepatology 44 (6), 1033-1039, 2006 | 100 | 2006 |
| NAD (P) H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats B Angermayr, M Fernandez, M Mejias, J Gracia-Sancho, ... Gut 56 (4), 560-564, 2007 | 96 | 2007 |
| CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis M Mejias, J Gallego, S Naranjo-Suarez, M Ramirez, N Pell, A Manzano, ... Gastroenterology 159 (1), 273-288, 2020 | 73 | 2020 |
| Sequential functions of CPEB1 and CPEB4 regulate pathologic expression of vascular endothelial growth factor and angiogenesis in chronic liver disease V Calderone, J Gallego, G Fernandez-Miranda, E Garcia-Pras, C Maillo, ... Gastroenterology 150 (4), 982-997. e30, 2016 | 72 | 2016 |
| Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats M Mejias, L Coch, A Berzigotti, E Garcia-Pras, J Gallego, J Bosch, ... Gut 64 (4), 657-666, 2015 | 60 | 2015 |
| Disruption of negative feedback loop between vasohibin‐1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats L Coch, M Mejias, A Berzigotti, E Garcia‐Pras, J Gallego, J Bosch, ... Hepatology 60 (2), 633-647, 2014 | 56* | 2014 |
| Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats M D'Amico, M Mejías, E García-Pras, JG Abraldes, JC Garcia-Pagan, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 302 (10 …, 2012 | 53 | 2012 |
| The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats M Mejias, E Garcia‐Pras, C Tiani, J Bosch, M Fernandez Journal of cellular and molecular medicine 12 (5a), 1690-1699, 2008 | 53 | 2008 |
| Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension M Coll, J Genescà, I Raurell, A Rodríguez-Vilarrupla, M Mejías, T Otero, ... Journal of hepatology 49 (1), 43-51, 2008 | 36 | 2008 |
| Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension E Garcia-Pras, J Gallego, L Coch, M Mejias, G Fernandez-Miranda, ... Gut 66 (7), 1306-1320, 2017 | 23 | 2017 |
| Pericytes in the Gut M Ramirez, N Pell, M Mejias, M Fernandez Pericyte Biology in Different Organs, 73-100, 2019 | 21 | 2019 |
| Therapeutic siRNA targeting endothelial KDR decreases portosystemic collateralization in portal hypertension J Gallego, E Garcia-Pras, M Mejias, N Pell, U Schaeper, M Fernandez Scientific Reports 7 (1), 14791, 2017 | 9 | 2017 |
| Pathogenesis of portal hypertension: extrahepatic mechanisms M Fernandez, M Mejias, E Garcia-Pras, J Gallego, N Pell, M Ramirez, ... Current Hepatology Reports 15, 199-207, 2016 | 3 | 2016 |
| Crosstalk between angiogenesis and fibrogenesis in liver disease M Mejias, A Balvey, M Fernandez Current Tissue Microenvironment Reports 1, 121-129, 2020 | 2 | 2020 |
| 504 EFFECTS OF THE COMBINED ADMINISTRATION OF SORAFENIB PLUS PROPRANOLOL ON PORTAL HYPERTENSION IN CIRRHOTIC RATS M D'Amico, M Mejias, E García-Pras, J Abraldes, JC García-Pagán, ... Journal of Hepatology, S203, 2010 | 2 | 2010 |
